BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28842590)

  • 1. DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.
    Chen WJ; Wang WT; Tsai TY; Li HK; Lee YW
    Sci Rep; 2017 Aug; 7(1):9411. PubMed ID: 28842590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mitotic centrosome localization preserves centrosome integrity and works as sensor for the mitotic surveillance pathway.
    Contadini C; Monteonofrio L; Virdia I; Prodosmo A; Valente D; Chessa L; Musio A; Fava LL; Rinaldo C; Di Rocco G; Soddu S
    Cell Death Dis; 2019 Nov; 10(11):850. PubMed ID: 31699974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
    Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
    Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation.
    Tritarelli A; Oricchio E; Ciciarello M; Mangiacasale R; Palena A; Lavia P; Soddu S; Cundari E
    Mol Biol Cell; 2004 Aug; 15(8):3751-7. PubMed ID: 15181149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.
    Li HK; Mai RT; Huang HD; Chou CH; Chang YA; Chang YW; You LR; Chen CM; Lee YH
    Sci Rep; 2016 Jun; 6():28637. PubMed ID: 27344963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 dependent centrosome clustering prevents multipolar mitosis in tetraploid cells.
    Yi Q; Zhao X; Huang Y; Ma T; Zhang Y; Hou H; Cooke HJ; Yang DQ; Wu M; Shi Q
    PLoS One; 2011; 6(11):e27304. PubMed ID: 22076149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability.
    Nam HJ; Chae S; Jang SH; Cho H; Lee JH
    Carcinogenesis; 2010 Sep; 31(9):1531-40. PubMed ID: 20584748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.
    Sun M; Zhou T; Jonasch E; Jope RS
    Biochim Biophys Acta; 2013 Jun; 1833(6):1489-97. PubMed ID: 23470959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortalin controls centrosome duplication via modulating centrosomal localization of p53.
    Ma Z; Izumi H; Kanai M; Kabuyama Y; Ahn NG; Fukasawa K
    Oncogene; 2006 Aug; 25(39):5377-90. PubMed ID: 16619038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation.
    Pek JW; Kai T
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12007-12. PubMed ID: 21730191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of threonine 204 of DEAD-box RNA helicase DDX3 by cyclin B/cdc2 in vitro.
    Sekiguchi T; Kurihara Y; Fukumura J
    Biochem Biophys Res Commun; 2007 May; 356(3):668-73. PubMed ID: 17379183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.
    Wang X; Wang R; Luo M; Li C; Wang HX; Huan CC; Qu YR; Liao Y; Mao X
    Oncotarget; 2017 May; 8(20):33197-33213. PubMed ID: 28402257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 is associated with the centrosome during mitosis.
    Hsu LC; White RL
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):12983-8. PubMed ID: 9789027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
    Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export.
    Choi YJ; Lee SG
    J Cell Biochem; 2012 Mar; 113(3):985-96. PubMed ID: 22034099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of centrosome amplification in radiation-induced mitotic catastrophe.
    Dodson H; Wheatley SP; Morrison CG
    Cell Cycle; 2007 Feb; 6(3):364-70. PubMed ID: 17297293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tobacco carcinogen NNK disturbs mitotic chromosome alignment by interrupting p53 targeting to the centrosome.
    Park JE; Jang YL; Jang CY
    Toxicol Lett; 2017 Nov; 281():110-118. PubMed ID: 28964810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
    Shih JW; Tsai TY; Chao CH; Wu Lee YH
    Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.